Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of recombinant monoclonal antibodies by capillary zone electrophoresis.
Espinosa-de la Garza CE, Perdomo-Abúndez FC, Padilla-Calderón J, Uribe-Wiechers JM, Pérez NO, Flores-Ortiz LF, Medina-Rivero E. Espinosa-de la Garza CE, et al. Among authors: perdomo abundez fc. Electrophoresis. 2013 Apr;34(8):1133-40. doi: 10.1002/elps.201200575. Epub 2013 Mar 20. Electrophoresis. 2013. PMID: 23417502
Pharmacokinetic Comparability of a Biosimilar Trastuzumab Anticipated from Its Physicochemical and Biological Characterization.
Miranda-Hernández MP, López-Morales CA, Piña-Lara N, Perdomo-Abúndez FC, Pérez NO, Revilla-Beltri J, Molina-Pérez A, Estrada-Marín L, Flores-Ortiz LF, Ruiz-Argüelles A, Medina-Rivero E. Miranda-Hernández MP, et al. Among authors: perdomo abundez fc. Biomed Res Int. 2015;2015:874916. doi: 10.1155/2015/874916. Epub 2015 Nov 19. Biomed Res Int. 2015. PMID: 26682224 Free PMC article. Clinical Trial.
New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept.
Miranda-Hernández MP, López-Morales CA, Perdomo-Abúndez FC, Salazar-Flores RD, Ramírez-Ibanez ND, Pérez NO, Molina-Pérez A, Revilla-Beltri J, Flores-Ortiz LF, Medina-Rivero E. Miranda-Hernández MP, et al. Among authors: perdomo abundez fc. J Immunol Res. 2016;2016:9697080. doi: 10.1155/2016/9697080. Epub 2016 Jun 12. J Immunol Res. 2016. PMID: 27382576 Free PMC article.
Response to: Comment on "New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept".
Miranda-Hernández MP, López-Morales CA, Perdomo-Abúndez FC, Salazar-Flores RD, Ramírez-Ibanez ND, Pérez NO, Molina-Pérez A, Revilla-Beltri J, Medina-Rivero E, Flores-Ortiz LF. Miranda-Hernández MP, et al. Among authors: perdomo abundez fc. J Immunol Res. 2018 Feb 21;2018:6156024. doi: 10.1155/2018/6156024. eCollection 2018. J Immunol Res. 2018. PMID: 29676408 Free PMC article. No abstract available.
Development and validation of a mass spectrometric method to determine the identity of rituximab based on its microheterogeneity profile.
Perdomo-Abúndez FC, Vallejo-Castillo L, Vázquez-Leyva S, López-Morales CA, Velasco-Velázquez M, Pavón L, Pérez-Tapia SM, Medina-Rivero E. Perdomo-Abúndez FC, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Feb 15;1139:121885. doi: 10.1016/j.jchromb.2019.121885. Epub 2019 Nov 27. J Chromatogr B Analyt Technol Biomed Life Sci. 2020. PMID: 31806401
Mono-PEGylated lysozyme purification with increased productivity and isomer differentiation through heparin monolith chromatography.
Mejía-Manzano LA, Campos-García VR, Perdomo-Abúndez FC, Medina-Rivero E, González-Valdez J. Mejía-Manzano LA, et al. Among authors: perdomo abundez fc. J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Jul 15;1204:123323. doi: 10.1016/j.jchromb.2022.123323. Epub 2022 Jun 7. J Chromatogr B Analyt Technol Biomed Life Sci. 2022. PMID: 35700648